Does Medicare cover pulmonary arterial hypertension medications like Veletri, Ventavis, or ambrisentan?

Answered by 8 licensed agents

Yes, all three medications are covered by Medicare, but under different parts, depending on how the drug is taken. Veletri is usually covered under Part B, with the pump covered as medical equipment. Under Original Medicare you pay 20%, but a Medigap plan can help cover that 20%, and under an Advantage plan you pay the plan’s copay instead.

Ventavis is also usually covered under Part B, along with the nebulizer. And just like with Veletri, you may pay 20% or an Advantage plan’s copay.

Since ambrisentan is a pill, it is covered under Part D, and it’s usually on the specialty tier of a plan’s formulary. The good news is that Part D has a yearly out-of-pocket cap: $2,100 for 2026 and $2,400 for 2027.

As your Medicare agent, I can always help you check which plan covers your PAH drugs and what each one would cost for the year.

Answered by Erick Vallarino on October 30, 2026

Agent Licensed in TX

Answered by Erick Vallarino Medicare Insurance Agent
Original Medicare does cover these medications. Veletri and Ventavis are generally covered under Medicare Part B while Ambrisentan is covered under Medicare Part D.

The distinction is that Medicare Part B covers medications given by injection or infusion in a provider's office or hospital setting. Part D medications are those purchased from a pharmacy and self-administered, whether orally or by injection or infusion.

Part B drugs generally incur 20% coinsurance, while Part D drugs have a copay that is subject to a plan's deductible and cost depending on the carrier's Tier structure. Be sure to confirm with your plan, whether it's a stand-alone prescription drug plan or a Medicare Advantage plan with drug coverage, whether the medications are on its formulary. If they are not, you may have to pay the full retail cost if the carrier won't provide an exception.

Answered by Kevin Swartz on November 2, 2026

Agent Licensed in OH

Answered by Kevin Swartz Medicare Insurance Agent
Yes, Medicare covers all three, but under different parts.

Veletri and Ventavis (Part B): Both need special equipment, an infusion pump or an inhalation device, so Medicare covers them under Part B as durable medical equipment. They usually come through a specialty pharmacy. You’ll need a confirmed PAH diagnosis (usually by right heart catheterization) and a pulmonologist or cardiologist managing your care.

Under Original Medicare, you pay 20% coinsurance, which adds up quickly on drugs this expensive. A Medigap plan like G or N covers that 20%. On a Medicare Advantage plan, you pay the plan’s cost share up to its yearly out-of-pocket maximum, and these drugs usually need prior authorization.

Ambrisentan (Part D): It’s a pill, so your Part D or Advantage drug coverage pays for it. It’s usually a specialty-tier drug and often needs prior authorization. In 2027, Part D costs are capped at $2,400 for the year, and you can spread that into monthly payments.

Before Open Enrollment ends December 7: check that ambrisentan is on your plan’s drug list, and confirm your specialty pharmacy is in-network. If your income is limited, apply for Extra Help.

Tips

Check the formulary of any Part D or Advantage plan you’re considering to confirm ambrisentan is covered, at what tier, and with what restrictions.

On an Advantage plan, ask whether your specialty pharmacy is in-network for both the Part B drugs and the Part D drug.

If your income is limited, apply for Extra Help. Also ask your PAH specialist’s office about foundation assistance.

Prices and plan rules change every year, so compare your options during Open Enrollment, which ends December 7.

Answered by Caroline Johnson on November 3, 2026

Agent Licensed in TX

Answered by Caroline Johnson Medicare Insurance Agent
Yes—Medicare can cover these pulmonary arterial hypertension medications, but coverage depends on the drug, how it is administered, and your plan’s requirements.

Veletri (epoprostenol), delivered through an infusion pump, and Ventavis (iloprost), taken through a specialized inhalation device, may qualify for Part B coverage when Medicare’s medical and equipment requirements are met. Oral ambrisentan is generally handled through Part D prescription coverage, subject to your plan’s formulary and any prior authorization requirements.

Before choosing a plan, have your exact medication, dosage, equipment supplier, and specialty pharmacy checked. This helps confirm both coverage and your expected costs. A Medicare agent can help review benefits while your prescribing specialist provides any required medical documentation.

Answered by Antonio Rodriguez on October 31, 2026

Broker Licensed in OR & ME

Answered by Antonio Rodriguez Medicare Insurance Agent
Yes, Medicare can cover these medications for pulmonary arterial hypertension, but they don’t all fall under the same part of Medicare.

• **Veletri (epoprostenol):** Generally covered under Part B when administered through a qualifying infusion pump and Medicare’s coverage requirements are met.

• **Ventavis (iloprost):** Generally covered under Part B when used with its covered inhalation device and the required medical criteria are met.

• **Ambrisentan:** Generally covered through Part D prescription coverage, depending on your plan’s covered-drug list and approval requirements.

The key is confirming the exact medication, how it’s administered, and your coverage before estimating your cost. Covered doesn’t necessarily mean paid in full. Contact us, and we can review your plan and coordinate with your specialty pharmacy to verify the details.

Answered by Leslie Kaz on November 2, 2026

Agent Licensed in CA, AL, AZ & 7 other states

Answered by Leslie Kaz Medicare Insurance Agent
Yes, Medicare may cover medications used to treat pulmonary arterial hypertension (PAH), including Veletri, Ventavis, and ambrisentan. Coverage depends on the medication, how it is administered, and your specific Medicare plan. Veletri (epoprostenol) and Ventavis (iloprost) may qualify for Medicare Part B coverage when administered through qualifying infusion or nebulizer equipment, while oral medications such as ambrisentan are generally covered under Part D. Prior authorization, medical necessity requirements, and out-of-pocket costs may apply. Because these medications can be expensive, it's important to verify coverage with your Medicare plan and prescribing specialist before starting treatment.

Answered by Ann Sanfelippo on October 30, 2026

Broker Licensed in FL, AL, AZ & 14 other states

Answered by Ann Sanfelippo Medicare Insurance Agent
Yes, Medicare can cover medications for pulmonary arterial hypertension, including these three, but coverage depends on the medication and how it is administered.

Veletri, given through a continuous IV infusion pump, and Ventavis, taken through a specialized inhalation device, can be covered under Part B when Medicare’s medical and equipment requirements are met. Ambrisentan is an oral medication generally handled through Part D prescription coverage, subject to your plan’s drug list and approval requirements.

Coverage does not necessarily mean there is no cost. A licensed Medicare agent can help verify which part of Medicare applies, review your expected expenses, and coordinate with your specialist and specialty pharmacy to confirm any required approvals.

Answered by Jeremy Harkins on October 29, 2026

Broker Licensed in TN, AR, CA & 5 other states

Answered by Jeremy Harkins Medicare Insurance Agent
Yes, Medicare can cover medications used to treat pulmonary arterial hypertension (PAH), including Veletri, Ventavis, and ambrisentan. However, how they're covered depends on the medication, how it's administered, and your specific Medicare plan.

For example, Veletri and Ventavis may qualify for coverage under Medicare Part B when administered through qualifying medical equipment, while ambrisentan is generally covered through Medicare Part D prescription drug plans.

These medications can be expensive, so it's especially important to check your plan's formulary, prior authorization requirements, specialty pharmacy rules, and out-of-pocket costs before making any coverage changes.

At McGirl Insurance, we know how important it is to have reliable access to medications for a serious condition like PAH. We're happy to help you review your Medicare coverage and understand your options.

Answered by Allen McGirl on November 5, 2026

Broker Licensed in CO, AK, AL & 40 other states

Answered by Allen McGirl Medicare Insurance Agent

Tags: Coverage Medicare Part D Prescription Drug

Agents: Share Your Expertise

Have insights or experiences related to this topic? Help others by sharing your knowledge and answering this question.

Seniors: Ask a Question of Your Own

Questions are generally answered within 1 to 3 business days. Receive valuable perspectives from multiple licensed agents and brokers.

Ask a Question